Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
0.5%
1w
2.1%
1m
2.9%
3m
1.5%
6m
8.0%
1y
24.3%
all
0.5%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec21Sep22Jun23Mar24Dec24Latest
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 190 0.5%
182
209
Company Overview
Sales
8,936 Cr
Growth: 7.1%
Profit after Tax
-44.5 Cr
Growth: -157.5%
Mid Cap
25,222 Cr
P/S: 2.8x
Industry P/S: 2.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals
Sales (Cr) ₹ 8,936
Growth 7.1%
EBITDA 13.0%
P/S 2.8x
Dividend 0.1%
P/E -1049.2x
Book Value ₹ 59.6
PEG Ratio -147.8x
ROE -0.6%
P/B 3.2x
Shareholding Pattern
Institutions
Created with Highcharts 8.2.2Sep22Sep23Dec23Jun24Sep24Jun25
Promoters
Created with Highcharts 8.2.2Sep22Sep23Dec23Jun24Sep24Jun25
Others
Created with Highcharts 8.2.2Sep22Sep23Dec23Jun24Sep24Jun25
Increase    Decrease    No change
Company Profile Detailed
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Belongs to (26 Indices) view more
Investors (6)
vskr63
chethan3
ravi_kum...
Followers (2)
saurabh8...
varsha96